CURRENT CLINICAL TRIALS
Clinical trials open and close on a regular basis, so check back often to stay up-to-date. If you’re interested in learning more about a particular study you can reach one of our research coordinators by calling 501.620.4449.
TRIALS AVAILABLE IN OUR HOT SPRINGS LOCATION:
ATOPIC DERMATITIS
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Study to Evaluate the Efficacy and Safety of XXXXX Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects
PLAQUE PSORIASIS
M16-005: A Multicenter, Single-Arm, Open Label, Assessor-Blinded Study to Assess the Usability of the XXXXX in Adult Patients with Moderate to Severe Plaque Psoriasis
MOLLUSCUM CONTAGIOSUM
A Phase 3 Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy and Safety of XXXXX and Vehicle Gel Once Daily in the Treatment of Molluscum Contagiosum
ACNE
A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm Parallel Group Study Comparing the Safety and Efficacy of XXXXX Gel and XXXXX Gel in the Treatment of Acne Vulgaris
HIDRADENITIS SUPPURATIVA
A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of XXXXX in Adult Subjects with Moderate to Severe Hidradenitis Suppurativa
CHRONIC PRURITIS
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Pilot Study to Investigate the Efficacy, Safety, and Tolerability of XXXXX in Reducing Pruritus in Diseases Characterized by Chronic Pruritus
PLAQUE PSORIASIS
A Multi-Center, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase 3 Study with Randomized Withdrawal and Retreatment to Evaluate the Efficacy and Safety of XXXXX in Subjects with Moderate-to-Severe Plaque Psoriasis
ROSACEA
A randomized, double-blind, parallel-group, three-arm, placebo-controlled, multi-site therapeutic equivalence study with clinical end points comparing test product XXXXX, 1% to Reference Product XXXXX, 1% in the treatment of moderate to severe persistent facial erythema of rosacea
PLAQUE PSORIASIS
A PHASE 2B, RANDOMIZED, DOUBLE BLIND, VEHICLE-CONTROLLED,PARALLEL-GROUP, DOSE RANGING STUDY TO ASSESS EFFICACY, SAFETY,TOLERABILITY AND PHARMACOKINETICS OF XXXXX TOPICAL CREAM APPLIED ONCE OR TWICE DAILY FOR 12 WEEKS IN PARTICIPANTS WITH MILD TO MODERATE CHRONIC PLAQUE PSORIASIS.
TRIALS AVAILABLE IN OUR BRYANT LOCATION:
PRURITIS / ATOPIC DERMATITIS
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of oral XXXXX for moderate to severe pruritus in adult subjects with atopic dermatitis
PLAQUE PSORIASIS
A Phase 3 Efficacy and Safety Study of XXXXX for the Treatment of Plaque Psoriasis in Adults
MOLLUSCUM CONTAGIOSUM
A Phase 3 Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy and Safety of XXXXX and Vehicle Gel Once Daily in the Treatment of Molluscum Contagiosum
ATOPIC DERMATITIS
PHASE 3B/4, MULTICENTER, RANDOMIZED, ASSESSOR BLINDED, VEHICLE AND ACTIVE XXXXX CONTROLLED, PARALLEL GROUP STUDY OF THE EFFICACY, SAFETY, AND LOCAL TOLERABILITY OF XXXXX, 2% IN PEDIATRIC AND ADULT SUBJECTS (AGES 2 YEARS AND OLDER) WITH MILD TO MODERATE ATOPIC DERMATITIS
ATOPIC DERMATITIS
A MULTICENTER, RANDOMIZED, PHASE 2, DOUBLE-BLIND, VEHICLECONTROLLED,PARALLEL GROUP COMPARISON STUDY TO EVALUATE THE SAFETY AND EFFICACY OF XXXXX CREAM IN ADOLESCENTS AND ADULTS WITH MILD TO MODERATE ATOPIC DERMATITIS
